Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Buy
12,579
+7,946
+172% +$917K 0.01% 605
2026
Q1
$554K Buy
+4,633
New +$608K 0.01% 761
2024
Q1
– Sell
-6,833
Closed -$781K – 1542
2023
Q4
$781K Sell
6,833
-27,163
-80% -$2.71M 0.01% 526
2023
Q3
$3.09M Buy
+33,996
New +$3.51M 0.06% 202
2022
Q3
– Sell
-6,084
Closed -$476K – 1120
2022
Q2
$476K Buy
+6,084
New +$502K 0.02% 428
2020
Q3
– Sell
-22,385
Closed -$1.45M – 943
2020
Q2
$1.45M Buy
+22,385
New +$1.48M 0.16% 192
2018
Q1
– Sell
-3,735
Closed -$256K – 775
2017
Q4
$256K Sell
3,735
-10,167
-73% -$675K 0.02% 433
2017
Q3
$871K Buy
+13,902
New +$831K 0.11% 192
2017
Q1
– Sell
-186,790
Closed -$9.25M – 897
2016
Q4
$9.25M Buy
+186,790
New +$9.47M 0.29% 90
2016
Q3
– Sell
-38,487
Closed -$1.72M – 761
2016
Q2
$1.72M Buy
+38,487
New +$1.67M 0.13% 171
2015
Q3
– Sell
-7,000
Closed -$259K – 338
2015
Q2
$259K Buy
+7,000
New +$255K 0.23% 113

Other funds holding XYL

Quadrature Capital's XYL Position: Q2 2026 in Review

Quadrature Capital increased its Xylem (XYL) stake by 172% in Q2 2026, buying an estimated $917K and bringing the position to 12,579 shares worth $1.49M. The position accounts for 0.01% of the portfolio, ranked #605.

Quadrature Capital first reported a position in XYL in Q2 2015 and has held it in 11 quarters since. The position peaked at $9.25M in Q4 2016. 1,103 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Quadrature Capital held 12,579 shares of Xylem worth $1.49M as of Q2 2026.
  • Quadrature Capital bought 7,946 Xylem shares in Q2 2026, an estimated $917K.
  • Xylem made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #605 holding.
  • Quadrature Capital first reported a position in Xylem in Q2 2015 and has held it in 11 quarters since.
  • Quadrature Capital's Xylem position peaked at $9.25M in Q4 2016.
  • 1,103 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.